Management of Locally Advanced Esophageal Cancer

被引：3

作者：

Thakur, Binay ^{[1
]}

Devkota, Mukti ^{[1
]}

Chaudhary, Manish ^{[1
]}

机构：

[1] BP Koirala Mem Canc Hosp, Dept Surg Oncol, Bharatpur, Nepal

来源：

JOURNAL OF NEPAL MEDICAL ASSOCIATION | 2021年 / 59卷 / 236期

关键词：

combined modality therapy; esophageal cancer; esophagectomy; SQUAMOUS-CELL CARCINOMA; PHASE-III TRIAL; CHEMORADIOTHERAPY PLUS SURGERY; DEFINITIVE CHEMORADIOTHERAPY; RADICAL SURGERY; PREOPERATIVE CHEMORADIOTHERAPY; PERIOPERATIVE CHEMOTHERAPY; SALVAGE ESOPHAGECTOMY; RADIOTHERAPY; CHEMORADIATION;

D O I：

10.31729/jnma.4299

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Esophageal cancer is diagnosed usually at a locally advanced stage. Surgery alone has less optimal results and a multimodality approach has been established as the standard of care for cII-III stages of esophageal cancer. This review focuses on the recent evidences of management of esophageal cancer with various variations in approaches in Eastern and Western countries. The major difference is the selection of induction treatment. Till the results of some ongoing trials become available, most of the evidences support neoadjuvant chemoradiation followed by surgery for squamous cell carcinoma and perioperative chemotherapy and surgery for adenocarcinoma.

引用

页码：409 / 416

页数：8

共 50 条

[31] ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS) [J].

Reynolds, J. V. ;

Preston, S. R. ;

O'Neill, B. ;

Baeksgaard, L. ;

Griffin, S. M. ;

Mariette, C. ;

Cuffe, S. ;

Cunningham, M. ;

Crosby, T. ;

Parker, I. ;

Hofland, K. ;

Hanna, G. ;

Svendsen, L. B. ;

Donohoe, C. L. ;

Muldoon, C. ;

O'Toole, D. ;

Johnson, C. ;

Ravi, N. ;

Jones, G. ;

Corkhill, A. K. ;

Illsley, M. ;

Mellor, J. ;

Lee, K. ;

Dib, M. ;

Marchesin, V. ;

Cunnane, M. ;

Scott, K. ;

Lawner, P. ;

Warren, S. ;

O'Reilly, S. ;

O'Dowd, G. ;

Leonard, G. ;

Hennessy, B. ;

Mc Dermott, R. .

BMC CANCER, 2017, 17

[32] Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial [J].

Shapiro, Joel ;

Van Lanschot, J. Jan B. ;

Hulshof, Maarten C. C. M. ;

van Hagen, Pieter ;

Henegouwen, Mark I. van Berge ;

Wijnhoven, Bas P. L. ;

van Laarhoven, Hanneke W. M. ;

Nieuwenhuijzen, Grard A. P. ;

Hospers, Geke A. P. ;

Bonenkamp, Johannes J. ;

Cuesta, Miguel A. ;

Blaisse, Reinoud J. B. ;

Busch, Olivier R. C. ;

ten Kate, Fiebo J. W. ;

Creemers, Geert-Jan M. ;

Punt, Cornelis J. A. ;

Plukker, John Th M. ;

Verheul, Henk M. W. ;

Bilgen, Ernst J. Spillenaar ;

van Dekken, Herman ;

van der Sangen, Maurice J. C. ;

Rozema, Tom ;

Biermann, Katharina ;

Beukema, Jannet C. ;

Piet, Anna H. M. ;

van Rij, Caroline M. ;

Reinders, Janny G. ;

Tilanus, Hugo W. ;

Steyerberg, Ewout W. ;

van der Gaast, Ate .

LANCET ONCOLOGY, 2015, 16 (09) :1090-1098

[33] Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis [J].

Sjoquist, Katrin M. ;

Burmeister, Bryan H. ;

Smithers, B. Mark ;

Zalcberg, John R. ;

Simes, R. John ;

Barbour, Andrew ;

Gebski, Val .

LANCET ONCOLOGY, 2011, 12 (07) :681-692

[34] Current Status and Future Prospects for Esophageal Cancer Treatment [J].

Sohda, Makoto ;

Kuwano, Hiroyuki .

ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 23 (01) :1-11

[35] Preoperative Chemoradiation Therapy Versus Chemotherapy in Patients Undergoing Modified En Bloc Esophagectomy for Locally Advanced Esophageal Adenocarcinoma: Is Radiotherapy Beneficial? [J].

Spicer, Jonathan D. ;

Stiles, Brendon M. ;

Sudarshan, Monisha ;

Correa, Arlene M. ;

Ferri, Lorenzo E. ;

Altorki, Nasser K. ;

Hofstetter, Wayne L. .

ANNALS OF THORACIC SURGERY, 2016, 101 (04) :1262-1270

[36] Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus [J].

Stahl, M ;

Stuschke, M ;

Lehmann, N ;

Meyer, HJ ;

Walz, MK ;

Seeber, S ;

Klump, B ;

Budach, W ;

Teichmann, R ;

Schmitt, M ;

Schmitt, G ;

Franke, C ;

Wilke, H .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (10) :2310-2317

[37] Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction [J].

Stahl, Michael ;

Walz, Martin K. ;

Stuschke, Martin ;

Lehmann, Nils ;

Meyer, Hans-Joachim ;

Riera-Knorrenschild, Jorge ;

Langer, Peter ;

Engenhart-Cabillic, Rita ;

Bitzer, Michael ;

Koenigsrainer, Alfred ;

Budach, Wilfried ;

Wilke, Hansjochen .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (06) :851-856

[38] A Risk Model for Esophagectomy Using Data of 5354 Patients Included in a Japanese Nationwide Web-Based Database [J].

Takeuchi, Hiroya ;

Miyata, Hiroaki ;

Gotoh, Mitsukazu ;

Kitagawa, Yuko ;

Baba, Hideo ;

Kimura, Wataru ;

Tomita, Naohiro ;

Nakagoe, Tohru ;

Shimada, Mitsuo ;

Sugihara, Kenichi ;

Mori, Masaki .

ANNALS OF SURGERY, 2014, 260 (02) :259-266

[39] Long-term survival outcomes after definitive chemoradiation versus surgery in patients with resectable squamous carcinoma of the esophagus: results from a randomized controlled trial [J].

Teoh, A. Y. B. ;

Chiu, P. W. Y. ;

Yeung, W. K. ;

Liu, S. Y. W. ;

Wong, S. K. H. ;

Ng, E. K. W. .

ANNALS OF ONCOLOGY, 2013, 24 (01) :165-171

[40]

Toh Y, 2006, ANTICANCER RES, V26, P2487

← 1 2 3 4 5 →